edaravone · Shionogi · NDA 209176
Radicava
Earliest generic entry, as listed · earliest of 2 marketed strengths
Open now
No marketed reference-listed strength; date taken from all listed strengths.
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 218349, Zydus Pharms · 209176-001Approved 22 Jul 2026Detected 25 Oct 2026Historical import
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209176 · 001 · RLD · discontinued | solution, intravenous | 30MG/100ML (0.3MG/ML) | open |
| 209176 · 002 · RLD · discontinued | solution, intravenous | 60MG/100ML (0.6MG/ML) | open |